Low-dose naltrexone reduced anxiety in persons with multiple sclerosis during the COVID-19 pandemic

Persons with multiple sclerosis (PwMS) have been considered at high risk for vaccination and/or acquisition of COVID-19 related to their reduced immune systems and daily regimen of immune suppressing therapy. Substantiated and unsubstantiated reports on these unknown circumstances increased anxiety...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaughlin, Patricia J., Odom, Laura B., Arnett, Peter A., Orehek, Shannon, Thomas, Gary A., Zagon, Ian S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643313/
https://www.ncbi.nlm.nih.gov/pubmed/36379151
http://dx.doi.org/10.1016/j.intimp.2022.109438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643313/
https://www.ncbi.nlm.nih.gov/pubmed/36379151
http://dx.doi.org/10.1016/j.intimp.2022.109438

Ejemplares similares